Dexferrum (American Regent, Inc.)


Welcome to the PulseAid listing for the Dexferrum drug offered from American Regent, Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: iron dextran
SUBSTANCE NAME: IRON DEXTRAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1998-10-01
END MARKETING DATE: 0000-00-00


Dexferrum HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDexferrum from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 1998-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-0134_af01fdb8-d3d7-4186-a58f-f58839f1ceb8
PRODUCT NDC: 0517-0134
APPLICATION NUMBER: NDA040024

Other IRON DEXTRAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.INFeD
American Regent, Inc.Dexferrum
General Injectables & Vaccines, IncInfed